Mary E. Godwin's most recent trade in Nautilus Biotechnology Inc was a trade of 47,031 Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on Sept. 23, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nautilus Biotechnology Inc | Mary E. Godwin | Senior VP, Operations | 23 Sep 2024 | 47,031 | 0 | - | 2.9 | 134,744 | Common Stock | |
Nautilus Biotechnology Inc | Mary E. Godwin | Senior VP, Operations | 23 Sep 2024 | 47,031 | 47,031 | - | 0.5 | 21,634 | Common Stock | |
Nautilus Biotechnology Inc | Mary E. Godwin | Senior VP, Operations | 23 Sep 2024 | 47,031 | 353,337 | - | - | Stock Option (Right to Buy) | ||
Nautilus Biotechnology Inc | Mary E. Godwin | Senior VP, Operations | 17 Sep 2024 | 35,000 | 400,368 | - | - | Stock Option (Right to Buy) | ||
Nautilus Biotechnology Inc | Mary E. Godwin | Senior VP, Operations | 17 Sep 2024 | 35,000 | 0 | - | 2.9 | 99,869 | Common Stock | |
Nautilus Biotechnology Inc | Mary E. Godwin | Senior VP, Operations | 17 Sep 2024 | 35,000 | 35,000 | - | 0.5 | 16,100 | Common Stock | |
Nautilus Biotechnology Inc | Mary E. Godwin | Senior VP, Operations | 01 Mar 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | ||
Nautilus Biotechnology Inc | Mary E. Godwin | Senior VP, Operations | 27 Feb 2023 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) |